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Abstract 
Introduction: Secondhand smoke (SHS) is a significant cause of acute respiratory illness (ARI) and 5 
times more common in indigenous children. A single-blind randomized trial was undertaken to determine 
the efficacy of a family centered SHS intervention to reduce ARI in indigenous infants in Australia and 
New Zealand. Methods: Indigenous mothers/infants from homes with ≥1 smoker were randomized to a 
SHS intervention involving 3 home visits in the first 3 months of the infants' lives (plus usual care) or 
usual care. The primary outcome was number of ARI-related visits to a health provider in the first year of 
life. Secondary outcomes, assessed at 4 and 12 months of age, included ARI hospitalization rates and 
mothers' report of infants' SHS exposure (validated by urinary cotinine/creatinine ratios [CCRs]), smoking 
restrictions, and smoking cessation. Results: Two hundred and ninety-three mother/infant dyads were 
randomized and followed up. Three quarters of mothers smoked during pregnancy and two thirds were 
smoking at baseline (as were their partners), with no change for more than 12 months. Reported infant 
exposure to SHS was low (≥95% had smoke-free homes/cars). Infant CCRs were higher if one or both 
parents were smokers and if mothers breast fed their infants. There was no effect of the intervention on 
ARI events [471 intervention vs. 438 usual care (reference); incidence rate ratio = 1.10, 95% confidence 
intervals (CI) = 0.88-1.37, p = .40]. Conclusions: Despite reporting smoke-free homes/cars, mothers and 
their partners continue to smoke in the first year of infants' lives, exposing them to SHS. Emphasis needs 
to be placed on supporting parents to stop smoking preconception, during pregnancy, and postnatal. 
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Original investigation
Abstract
Introduction: Secondhand smoke (SHS) is a significant cause of acute respiratory illness (ARI) and 
5 times more common in indigenous children. A single-blind randomized trial was undertaken to 
determine the efficacy of a family centered SHS intervention to reduce ARI in indigenous infants 
in Australia and New Zealand.
Methods: Indigenous mothers/infants from homes with ≥1 smoker were randomized to a SHS 
intervention involving 3 home visits in the first 3 months of the infants’ lives (plus usual care) or 
usual care. The primary outcome was number of ARI-related visits to a health provider in the first 
year of life. Secondary outcomes, assessed at 4 and 12 months of age, included ARI hospitalization 
rates and mothers’ report of infants’ SHS exposure (validated by urinary cotinine/creatinine ratios 
[CCRs]), smoking restrictions, and smoking cessation.
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Results: Two hundred and ninety-three mother/infant dyads were randomized and followed up. Three 
quarters of mothers smoked during pregnancy and two thirds were smoking at baseline (as were their 
partners), with no change for more than 12 months. Reported infant exposure to SHS was low (≥95% 
had smoke-free homes/cars). Infant CCRs were higher if one or both parents were smokers and if moth-
ers breast fed their infants. There was no effect of the intervention on ARI events [471 intervention vs. 
438 usual care (reference); incidence rate ratio = 1.10, 95% confidence intervals (CI) = 0.88–1.37, p = .40].
Conclusions: Despite reporting smoke-free homes/cars, mothers and their partners continue to 
smoke in the first year of infants’ lives, exposing them to SHS. Emphasis needs to be placed on 
supporting parents to stop smoking preconception, during pregnancy, and postnatal.
Introduction
In Australia and New Zealand (NZ), deaths and hospitalization 
among indigenous children aged 0–4 years, due to acute respiratory 
illness (ARI), is higher compared with nonindigenous children (1–3). 
Secondhand smoke (SHS) exposure is the most modifiable risk fac-
tor for ARI among these populations. The effect of parental smoking 
on the frequency and severity of respiratory illness, asthma, otitis 
media, and chronic middle ear effusion is strongest in younger chil-
dren (4–11). The World Health Organization has prioritized the need 
to educate parents about the impact of SHS on children’s health (12), 
especially among populations with high smoking rates. Indigenous 
Australians and NZ Māori are twice as likely to smoke as their non-
indigenous counterparts (13,14), and thus indigenous children in these 
countries have greater SHS exposure (3,15,16).
A systematic review of 36 randomized trials that investigated fam-
ily/carer tobacco control programs for reducing children’s exposure 
to SHS found insufficient evidence to support any one intervention 
(17). However, a modest effect was found for intensive parental coun-
seling that focused on changing attitudes and behaviors, premised on 
behavior change theory (18), as opposed to changing knowledge alone. 
More recent trials support this finding (19,20). Qualitative research on 
smoking in remote Northern Territory Aboriginal communities has 
found that indigenous parents/carers are concerned about the health 
effects of SHS (21,22). In addition to positive role modeling, the health 
of their children is their primary motivation to quit (23). NZ Māori 
similarly stop smoking for the benefit of their children (24,25). These 
data suggest that a family-based SHS intervention that focuses more 
on the welfare of children as opposed to adults stopping smoking may 
be particularly salient among these two indigenous populations. Thus, 
we undertook a randomized trial with blinded outcome assessment 
to determine the impact of a culturally appropriate, family-centered 
SHS program (where we involved as many extended family members 
as possible and focused on strategies for reducing SHS exposure in 
children, which included positive role modeling, within family sup-
port and smoking cessation support for all) on the respiratory health 
of indigenous infants in Australia and NZ. We hypothesized that such 
a program would reduce the number of ARI-related visits to a health 
provider in the first year of infants’ lives.
Methods
Participants
The rationale and methodology for this trial has been reported pre-
viously (26) and is summarized below. Between December 2009 and 
January 2012, Community Workers (CWs) in Darwin, Australia, 
and Auckland, NZ, approached potentially eligible mothers through 
antenatal clinics and hospital birth records. Mother/infant dyads 
were eligible if (a) the infant was aged between 0–5 weeks; (b) the 
mother self-identified as Māori or Australian Aboriginal/Torres Strait 
Islander; (c) the mother was aged ≥16 years; (d) the mother was a cur-
rent smoker or the infant lived in a household where there was at least 
one other smoker; (e) the mother resided permanently with the infant 
in Darwin/Greater Darwin area of Australia or within the Counties 
Manukau District Health Board region, NZ; (f) the infant was a sin-
gleton or the first born in a multiple pregnancy delivery; and (g) the 
mother spoke English and/or Māori. Ethics approval was obtained 
from the Menzies Human Research Ethics Committee (Australia) and 
the Northern Region Human Ethics Committee (NZ).
Randomization and Blinding
Eligible and interested mothers were consented and mother/infant 
dyads were randomized in a 1:1 ratio to one of two arms by cen-
tral computer, using blocked randomization stratified by country 
(Australia, NZ). Participants were not blinded to treatment alloca-
tion, but research staff assessing the primary outcome were blinded.
Intervention
The control group received “usual care” comprising standard man-
agement by hospital and primary care providers, which ranged from 
brief quit advice to the provision of cessation treatment. In the inter-
vention group, all mothers (and family members that were present) 
who smoked received usual care plus behavioral “coaching” about 
the dangers of SHS exposure to children, commitment to smoking 
restrictions in the home/car, positive role modeling, and strategies 
for overcoming obstacles to making smoke-free changes. Those who 
smoked were also given either brief advice or more intensive coun-
seling to quit (depending on how receptive they were) and offered 
free nicotine replacement therapy (NRT; 21 mg patches and/or 4 mg 
gum) and/or a Quitline referral, unless it became clear as part of the 
conversation with them that they were not interested in such options. 
The program was founded on Māori and Aboriginal holistic models 
of health (24,27,28) and was delivered by CWs (who were mainly indige-
nous and received identical training in motivational interviewing and 
program delivery) through three face-to-face home visits conducted 
over the first 3  months of the infants’ lives. Both groups received 
brief health promotion messages (focused on immunization, infant 
nutrition/breast feeding, and safe sleeping for baby) from the CWs at 
baseline and when the infants were 4 and 12 months of age.
Outcomes
Baseline data were collected through a face-to-face visit at the mothers’ 
homes, as close as possible to 6 week after the infants’ birth. Baseline 
measures are described in detail in the published protocol (26). In the 
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quantitative and qualitative process evaluation indicators was collected 
related to the program delivery, including the amount of the program 
that was delivered, commitment to smoke-free changes, and parent sat-
isfaction. No information was collected on usual care practices.
Outcome data were collected at 4 and 12 months of age via a 
face-to-face visit at mothers’ homes. The primary outcome was rate 
of health provider presentations for new primary episodes of ARI 
in the first year of life, obtained from the mothers and confirmed by 
two study clinicians in each country (blinded to treatment alloca-
tion), who reviewed the infants’ health provider and hospital clinic 
records. In Australia, 20 participants had their primary outcome data 
reviewed by clinicians in NZ, in order to assess intercountry reliability. 
Secondary outcomes included rate of hospitalizations for ARI, moth-
ers’ breast feeding status (29) and self-report of smoking restrictions in 
the home (“Is smoking ever allowed inside the house?”—reported as 
Yes/No, but multiple options were allowed, e.g., Yes—but restricted 
to certain rooms only, Yes—in any room but only when the infant is 
not there) and car (“Is smoking allowed inside any car when your 
infant is in it?”—Yes/No option). Data were also collected on the 
mothers’ report of their infants’ exposure to SHS in the last 7 days, 
specifically whether the infant had been near (within arm’s length) 
people smoking cannabis or an open fire used for cooking/heating or 
a camp fire, whether they had been around tobacco smoke (e.g., in 
the same room in a house as someone that was smoking, in a car with 
someone that was smoking, or sitting outside within arm’s length of 
someone who was smoking), and whether they had been cared for in 
other houses or childcare where people smoked. Mothers’ self-report 
of a quit attempt was also asked, defined as not smoking a cigarette 
for ≥24 hr, as was the presence of day- and nighttime coughing by the 
infant over the last 2 days (using verbal category descriptive scores 
from 0–5, as per Chang et al. (30).
To confirm SHS exposure in the last 2–3 days, a single urine sam-
ple was collected from each infant (31) at baseline, 4 months, and 
12 months of age (26). Samples were tested for urinary cotinine and 
creatinine using gas chromatography/mass spectrometry. Results are 
expressed as the cotinine/creatinine ratio (CCR, ng/mg), with values 
of ≥30 ng/mg indicating that the infant was exposed to SHS (sensitiv-
ity 80%, specificity 100%) (32).
Sample Size/Analyses
A study of disease burden and clinic attendances for young indig-
enous children in two remote Northern Territory communities 
found the median number of presentations for upper respiratory 
illness in the first year of life was 7.5 (interquartile range 4–11) 
and for lower respiratory illness, 2.5 (interquartile range 1–5) (33). 
Our clinical experience with infants and limited data from children 
suggested that there would be much fewer episodes of ARI in urban 
compared with remote settings (34). Thus, it was estimated that an 
average of three visits per year would occur in the control group. 
Each population had a sample size estimate of 210 mother/infants 
dyads, which provided 90% power (p = .05) to detect a 25% reduc-
tion in new episodes of ARI in the intervention group compared 
with the usual care group (based on three health provider visits 
per year in the usual care group and 2.25 visits in the intervention 
group), assuming a Poisson distribution and a 10% loss to follow-
up. Combining data from the two countries (n  =  420) provided 
90% power (p = .05) to detect an 18% reduction in the primary 
outcome.
All analyses were undertaken using SAS Version 9.3. Complete 
case analysis was undertaken, and sensitivity analyses using a 
modified intention-to-treat (ITT) approach (excluding those rand-
omized but who did not enter the protocol) with a multiple imputa-
tion method (using 50 imputations) applied to the missing data (35) 
and analyses adjusted for potential confounding factors. The inci-
dence rate for ARI between the two groups was analyzed using neg-
ative binomial regression as there was evidence of overdispersion. 
The incidence rate ratio (IRR) and 95% confidence intervals (95% 
CI) were reported (with usual care as the reference). Dichotomous 
outcomes were compared using chi-square tests and continuous out-
comes were compared using T-tests or Mann–Whitney tests. Due 
to the skewed nature of the CCR data, they were log transformed 
and presented as geometric means. The difference between groups in 
log-transformed CCR are presented as a ratio of geometric means 
(95% CI) and adjusted (using linear regression) for infants’ birth 
weight and baseline measures of CCR, mothers’ age, education, 
smoking status, breast feeding status, and crowding index. For log-
transformed values that were not significantly different, the 95% CI 
of the ratio included 1. Intra-rater and intercountry agreement for 
grading of the primary outcome assessment were assessed using the 
Kappa statistic (unweighted).
Results
Overall, 228 mother/infant dyads were recruited in NZ (115 inter-
vention, 113 usual care) and 93 in Australia (46 intervention, 47 
usual care). Recruitment took 14  months in NZ and stopped at 
28  months in Australia due to not reaching the recruitment tar-
get within the budgeted timeframe. More potential participants in 
Australia declined to participate (56%) than those in NZ (31%, 
p < .001), and more were noncontactable in NZ (39% NZ vs. 7% 
Australia, p < .001). Rates of withdrawal and ineligibility after ran-
domization and before baseline assessment did not differ between 
country or by treatment group (Figure 1).
A total of 293 participants were available for follow-up, with 
a total 12-month loss-to-follow-up (including withdrawal and 
death) of 13% (39/293) and with no significant difference by treat-
ment group, country, or their interaction. No significant differences 
in baseline data between the two countries were found, and thus 
the two data sets were combined (Table 1), with results presented 
hereafter.
In the intervention group at baseline, 2 months, and 3 months, all 
but 2, 8, and 17 households, respectively, received the intervention. 
Not all parts of the program were implemented in every household, 
due to the mother and/or family members wanting to move the con-
versation on or stop the interview. Across the baseline, 2-month and 
3-month visits, only 2%–7% of the mothers/family members failed 
to agree to smoking restrictions inside the home and car.
Primary Outcome
The rate of health provider presentations for new primary episodes 
of ARI in the first year of life did not differ significantly between 
the groups (intervention: 471 events; usual care: 438 events; 
IRR = 1.10, 95% CI = 0.88–1.37, p = .40). Results were similar 
for ITT analysis (IRR = 1.10, 95% CI = 0.88–1.36, p = .41) and 
after adjusting for infants’ birth weight, mother’s age at baseline, 
education, smoking status, breast feeding status, and crowding 
index (IRR = 1.07, 95% CI = 0.86–1.34, p = .53). No differences 
in the primary outcome were found according to new episodes 
of upper respiratory tract infection (intervention: 315 events; 
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lower respiratory tract infection (intervention: 147 events; usual 
care: 167 events; IRR = 0.90, 95% CI = 0.65–1.25, p = .53), otitis 
media (intervention: 105 events; usual care: 95 events; IRR = 1.13, 
95% CI  =  0.74–1.73, p  =  .58), or rate of hospitalizations for 
ARI (intervention: 53 events; usual care: 44 events; IRR = 1.23, 
95% CI = 0.70–2.15, p = .47). Between country, interrater agree-
ments for lower respiratory tract infection, upper respiratory tract 
infection, and otitis media were high (κ  = 0.84, 0.78, and 0.79, 
respectively).
Secondary Outcomes
Mothers’ Report on Infants’ Exposure to SHS
Three quarters of mothers smoked during their pregnancy, and two 
thirds were current smokers at baseline (Table  1). No significant 
change in smoking prevalence and intensity was seen by group over 
the first year of the infants’ lives (Table 2). Of the 238 mothers (80%) 
who had a partner at baseline, 164 (69%) reported that their part-
ner smoked, with no difference in this proportion by group or over 
time (Table 2). The geometric mean CCRs were significantly higher if 
Assessed for eligibility (n=1156)
Allocated to Intervention (n=145)
Completed baseline assessment 
Allocated to usual care (n=148)
Completed baseline assessment 
Four months (n=134)
Lost to follow-up (n=10, 7%)
Participants withdrawn (n=1)
Four months (n=132)
Lost to follow-up (n=14, 9%)
Participants withdrawn (n=2)
12 months (n=126)










No contact (n=265,32% )
Othera (n=30, 4%)
Complete case analysis (n=143)
Total of 2 participants withdrew
Complete case analysis (n=146)





















a One infant died at birth, four were placed into care/adopted, 12 mothers were 
excluded due to socio-emotional issues (e.g. Domestic violence, substance 
abuse etc) and 13 did not proceed in Australia after recruitment was stopped.
b We do not know why the 14 women/infants (all from New Zealand) did not go 
onto to get randomised, despite being eligible.
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parents smoked (mother and partner smoked: 365 ng/mg; mother only 
smoked: 245 ng/mg; partner only smoked: 27 ng/mg) compared with 
neither parent smoking (25 ng/mg; p < .0001). Breast feeding rates 
were high at baseline, with this proportion declining over time and no 
difference noted by group (Table 2). Mean CCRs were significantly 
higher at baseline and 4 months in those mothers breast feeding their 
infants compared with artificial feeding (both p < .001), with no dif-
ference at 12 months (p = .09; Figure 2). Overall, mean CCRs declined 
Table 1. Baseline Characteristics of Infant and Mother (New Zealand and Australia Combined)
Variables Intervention group, N = 145 (%) Usual care group, N = 148 (%)
Infants: female 58 (40) 68 (46)
Infants: mean age at baseline, weeks (SD) 6.3 (2.7) 6.0 (2.7)
Infants: country
 New Zealand 108 (74) 108 (73)
 Australia 37 (26) 40 (27)
Infants: mean gestational age at birth, weeks (SD) 39.3 (1.3) 39.3 (1.5)
Infants: mean birth weight, kilograms (SD) 3.3 (0.5) 3.3 (0.6)
Infants: unwell since birtha 44 (30) 36 (24)
Infants: coughing
 No daytime cough 111 (77) 119 (80)
 No nighttime cough 123 (85) 128 (87)
Mothers: mean age at baseline in years (SD) 26.8 (6.5) 25.3 (5.8)
Mothers: highest level of education
 ≤Secondary school 104 (72) 114 (77)
 TAFE/polytechnic/university 41 (28) 34 (23)
Mothers: marital statusb
 Married/defacto/living with partner 72 (50) 91 (62)
 Divorced/separated/widowed 8 (6) 20(14)
 Never married 44 (30) 25 (17)
 Refused to answerc 21 (15) 12 (8)
Mothers: breast feeding state
 Yes—exclusive 43 (30) 49 (33)
 Yes—full 29 (20) 31 (21)
 Yes—partial 42 (29) 40 (27)
 No 31 (21) 28 (19)
Mothers: smoked during pregnancy 114 (79) 105 (71)
Mothers: reduced amount smoked during pregnancye 74 (65) 71 (68)
Mothers: current smoking status
 Current smoker 105 (72) 88 (60)
 Ex-smoker 22 (15) 37 (25)
 Never smoked 18 (12) 23 (16)
Mothers: frequency of smokingf
 At least weekly 95 (90) 83 (94)
 Less than weekly 10 (10) 5 (6)
Mothers: number of cigarettes smoked per dayf
 ≤10 54 (51) 63 (72)
 11–20 38 (35) 20 (23)
 21–30 6 (6) 2 (2)
 ≥31 1 (1) 1 (1)
 Missing data 6 (6) 2 (2)
Mothers: time to first cigarettef
 ≤30 min of waking 48 (49) 31 (37)
 >30 min of waking 50 (51) 53 (63)
Mothers: quit attempt in last 12 monthsf 49 (47) 44 (50)
Mothers: mean self-efficacy score (SD)g 3.3 (0.8) 3.3 (0.8)
Household: mean crowding index (SD)d 2.0 (0.7) 2.0 (0.7)
Household: mean number of children in house aged under 5 years (SD) 1.9 (1.0) 1.9 (1.0)
SD = standard deviation; TAFE = Technical and Further Education Institution.
aThe specific question was “Has your infant been unwell and needed to go to the health clinic, general practitioner or hospital since he/she was born?”
bX2; p = .002.
cAll but three participants were from New Zealand. In New Zealand, different levels of social support are offered depending on marital status. It is likely that some 
women in the study did not wish to disclose their marital status, in case their access to certain social support was jeopardized.
dDefined as the number of people currently sleeping in the house divided by the number of rooms in the house where people were sleeping
eIn those that smoked during pregnancy.
fIn current smokers.
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over time to <30 ng/mg by 12 months of age, indicative of little SHS 
exposure (Table 2). After adjusting for baseline variables (including 
baseline CCR), there was no significant difference in mean CCRs 
between the groups at 4  months (ratio of geometric mean differ-
ence = 1.39, 95% CI = 0.99–1.94, p = .06) or 12 months of age (ratio 
of geometric mean difference = 0.97, 95% CI = 0.69–1.37, p = .87).
Smoking bans were reportedly well established with ≥95% 
smoke-free homes/cars at baseline, and mothers’ report of infants’ 
exposure to SHS in the last 7 days was relatively low. Both variables 
did not differ by group and did not significantly change over time 
(Table 2). Overall, in the last 7 days ≤18% of infants were poten-
tially exposed to SHS through being cared for in other places where 
people smoke, being in the same room in a house with someone 
that was smoking, being in a car with someone that was smoking, 
or sitting outside within arm’s length of someone who was smoking 
(Table 2). In the last 7 days, ≤8% of infants had been near an open 
fire for cooking/heating, or a camp fire, and ≤2% of infants had been 
near people smoking cannabis (Table 2).
Quitting Behavior
At baseline, almost half of the 193 mothers that were current smok-
ers had tried to quit smoking in the last 12 months (Table 1). When 
asked about their belief in their ability to quit smoking this time, 
measured on a scale of 1–5, where one was very low and five was 
very high, mothers had a mean self-efficacy score of 3.3 (SD = 0.8; 
Table 1). Across the baseline, 2-month, and 3-month visits, 24%–
30% of the mothers in the intervention group that smoked agreed 
to quit smoking (p = .55), 65%–87% were offered free NRT (70% 
acceptance at baseline, which was significantly more than at 2 and 
3 months: 32% and 41%, respectively, p = .0004), and 20%–43% 
were offered Quitline referrals (2-month data were significantly 
greater than those at baseline and 1 month: p = .0006, all refused the 
offer at baseline and 2 months; 7% accepted the offer at 3 months). 
Follow-up of infants at 4 and 12 months of age showed no difference 
between the groups in mothers’ quitting behavior over time. At 
4 months, 24% (41/172) of the current smokers had made a quit 
attempt, and 33% (51/153) at 12 months. No difference in 7-day 
point prevalence abstinence for mothers was seen between the two 
groups when their infants were 4 months (n = 25, 19% intervention 
vs. n = 34, 26% usual care, p = .16) or 12 months of age (n = 22, 
18% intervention vs. n = 33, 26% usual care, p = .10).
As part of the intervention program, other family members that 
smoked were also supported to quit smoking. When the infants 
were ~1 month old, in 37 families other members of the household 
(N = 58, mean = 1.6 people/household, SD = 0.8) were given a brief 
cessation intervention or more intensive counseling to stop smoking, 
of which 32 people in 17 (50%) families agreed to quit. From 53 
households, a total of 73 family members were offered free NRT (of 
which 61 people or 84% accepted). Thirteen people from 12 house-
holds were offered a referral to Quitline (of which none accepted). 
Similar findings were found when the infants were seen at 2 and 
3 months of age (data not reported).
Other Outcomes
Across the baseline (Table  1), 4-month, and 12-month visits, 
77%–88% of infants had no parent-reported daytime cough and 
75%–93% had no nighttime cough, with no statistical differences 
over time or by group. The majority (n  =  126, 93%) of the 135 
mothers in the intervention group who were interviewed when their 
infant was 3  months old felt that the program was “helpful” or 
“very helpful” for reducing SHS exposure in their child. Almost all 
(n = 131, 97%) were “satisfied” or “very satisfied” with the program.
Discussion
This trial tested whether a family-based SHS intervention focusing 
predominately on the health of infants, as opposed to smoking ces-
sation in adults, had any effect on the number of health provider 
BF: Breastfeeding
Exclusive BF: Baby has never received anything else apart from breast milk since birth, 
except for prescription medication; Full BF: Breast milk in the last 48 hours; Partial BF: 
Some breast milk and some formula or other food in the last 48 hours; Artificial: no breast 
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presentations by infants for ARI over a 12-month period. Although 
previous research suggested that such an intervention would lead to 
reduced exposure to SHS for infants (17,36), we found no effect on 
SHS exposure, parental smoking, or ARI. Mothers reported expo-
sure of the infant to SHS was low. However, mean urinary CCRs in 
the infants at baseline and at 4 months of age were consistent with 
SHS exposure. A recent U.S. trial (n = 138) looking at the effective-
ness of a community-based motivational intervention to reduce SHS 
exposure in children under six in low-income communities reported 
similar findings (37).
Possible explanations for why the trial infants had high CCRs 
in the first 4 months of life are addressed below and include expo-
sure to maternal nicotine/cotinine via breast milk, and/or unreported 
or underestimated SHS exposure by mothers. It is unlikely that the 
CCRs observed can be solely explained by high smoking rates in 
pregnancy, as prenatal exposure to nicotine is not measureable 3–6 
weeks after birth (38), which was when the first urine samples were 
collected. Elevated CCRs in breast-fed infants has previously been 
noted (39–42) and is likely due to the transmission of nicotine metabo-
lites in the milk of mothers who smoked and/or were exposed to 
high levels of SHS.
Breast milk cotinine levels have been shown to peak 30–60 min 
after smoking 1–2 cigarettes and dissipate after 3 hrs (43). Cotinine 
does not appear to have any pharmacological or toxicological prop-
erties of concern and thus is unlikely by itself to cause any adverse 
health effects for infants (42). However, it is unknown whether carci-
nogenic substances present in SHS are transferred to breast milk and 
thus to infants. Breast feeding has been shown to modify the effect 
of maternal smoking, such that the risk of ARI is decreased (44). As 
the infants aged and became increasingly mobile, their mean CCRs 
declined. Use of NRT by mothers trying to quit smoking may also 
have resulted in increased nicotine exposure for infants via breast 
milk (45), leading to increased CCRs. Approximately 50% of moth-
ers in the intervention arm were offered NRT, but we did not record 
whether they used it, and it is unknown how many mothers in the 
usual care arm were offered and used NRT as part of usual care.
Unreported SHS exposure may also be an explanation for the 
elevated CCRs. Previous research has shown that the association 
between infant cotinine levels and parental smoking is in part due to 
cosleeping and minimum room temperature (46). We did not consider 
these variables and thus are unable to comment on their influence. 
Underestimating SHS exposure is another possibility. Some infants 
may have been exposed to SHS in spite of families having smoke-free 
rules, or without their mother recalling this exposure.
Some of the trials’ strengths are that it was conducted in line 
with CONSORT guidelines, assessment of the primary outcome 
was blinded, and family members were involved. The complex 
reasons for the slow recruitment (especially in Australia) and high 
participant retention rate are discussed in a recent paper by Glover 
et  al. (47). A  number of limitations should be acknowledged: (a) 
mothers’ reported infant SHS exposure and breast feeding status 
may be affected by social desirability bias. Advertising campaigns 
ran in both countries before and during the study period promot-
ing the importance of breast feeding, smoking cessation, and not 
exposing children to SHS. Consequently, breast feeding may have 
been over-reported and SHS exposure under-reported, biasing the 
results toward the null (although not differentially). No measure-
ments of home/car air quality were taken as verification of reported 
infant SHS exposure; (b) the number of ARI events was consid-
erably lower than previously reported in a remote indigenous 
community setting (48), meaning our findings may not be gener-
alizable to populations with higher rates of ARI. In Darwin, we 
hand-searched all hospital records and the primary care records 
of the largest Aboriginal Medical Service. However, we may have 
missed cases that attended mainstream primary care services and 
were not reported by mothers. In NZ, we electronically searched 
primary care and hospital records within the region for ARI cases 
but with limited data linkage cases of ARI that occurred outside of 
the region may have been missed (again, this bias was unlikely to 
be differential); (c) the mothers that we were unable to contact or 
those that declined to participate may have been the ones who did 
not have strong smoke-free policies in place and thus were the ones 
this intervention could have helped the most; (d) the total num-
ber of cigarettes smoked in the home is reported as a key predic-
tor of cotinine levels in children (49). However, we did not assess 
this variable as indigenous Australians report significant sharing of 
cigarettes (23), making accurate measurement of “cigarettes smoked 
per day” difficult. In hindsight, we should have asked this question 
and acknowledged the potential misclassification; (e) as part of the 
intervention, information was provided to mothers about the nega-
tive health effects (including ARI) of SHS exposure on children. It 
can be hypothesized that mothers increased awareness of ARI may 
have increased their engagement with health care specialists about 
their infants’ health, thereby reducing any differences between the 
groups; (f) the proportion of smoke-free homes and cars reported in 
this study were much higher than reported by adults in population 
surveys (3,15,16,50,51), which raises some concerns about the generaliz-
ability of our findings to other populations; (g) we did not record 
use of NRT by mothers trying to quit smoking, so are unable to 
discuss the effect of NRT use on CCRs; and (h) we did not record 
“partner” versus “other family member” involvement in the study, 
so are unable to report findings according to these two groups.
Research has shown that having smoke-free homes (17,36) and 
smoking outside or away from infants can reduce SHS exposure 
but does not offer complete protection as the dust, air, and surfaces 
within homes remains contaminated (52). Future research therefore 
needs to focus on not only supporting mothers, their partners, and 
other family members to stop smoking but also on how to reduce 
children’s exposure to third-hand smoke. Personalized feedback on 
indoor air quality and CCR levels to families also has the potential 
to increase the effectiveness of future interventions (19,53). Future 
research should also investigate why these populations had no 
interest in Quitline support, although qualitative research from 
NZ (n = 168, 53% Māori) suggests awareness of the service, time 
required, and personal relevance may play some role (54).
In summary, our family-centered intervention to reduce exposure 
to SHS had no effect on rates of ARI in indigenous infants or on 
smoking and quitting behavior. These findings suggest that simply 
having smoke-free homes and cars is not sufficient to protect chil-
dren from exposure to SHS—all household members who smoke 
should stop smoking from the time of conception and should con-
tinue to be smoke-free after the child is born (55). Furthermore, breast 
feeding should continue to be encouraged, but smoking while breast 
feeding should be discouraged.
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